Aims & Scope

This journal is devoted to timely reviews and original articles of experimental and clinical studies in the field of endocrine, metabolic, and immune disorders. Specific emphasis is placed on humoral and cellular targets for natural, synthetic, and genetically engineered drugs that enhance or impair endocrine, metabolic, and immune parameters and functions. Moreover, the topics related to effects of food components and/or nutraceuticals on the endocrine-metabolic-immune axis and on microbioma composition are welcome.

《Endocrine Metabolic & Immune Disorders-drug Targets》是一本由BENTHAM SCIENCE PUBL LTD出版商出版的专业医学期刊，该刊创刊于2001年，刊期6 issues/year，该刊已被国际权威数据库SCIE收录。在中科院最新升级版分区表中，该刊分区信息为大类学科：医学 4区，小类学科：内分泌学与代谢 4区；免疫学 4区；药学 4区；在JCR（Journal Citation Reports）分区等级为Q4。该刊发文范围涵盖内分泌学与代谢等领域，旨在及时、准确、全面地报道国内外内分泌学与代谢工作者在该领域取得的最新研究成果、工作进展及学术动态、技术革新等，促进学术交流，鼓励学术创新。2021年影响因子为2.387，